Archive - April 2022
ViGeneron and Daiichi Sankyo to develop therapy for eye diseases
Cancer Research UK drives innovation with Cancer Research Horizons
Stress-Related Disorders Prevalent In Relatives Of COVID-19 ICU Patients: A ‘Secondary Public Health Crisis’
FDA Approves Epsolay (benzoyl peroxide) Cream for the Treatment of Rosacea
Veklury (remdesivir) is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19
Gilead’s Veklury significant decreases risk of hospitalisation for COVID-19 patients
Biogen retracts EMA application for Alzheimer’s drug Aduhelm
Novartis UK launches local charity partnerships to support social mobility pledges